CrossrefInfokarte
Galectin-3 as a Candidate Marker of Endocrine-modulator-associated Endometrial Remodeling During Breast Cancer Endocrine Therapy
In Vivo · 2026-11 · 40 (6) · 3519-3539
DOI: 10.21873/invivo.14494 ↗Abstract
Kein Abstract verfügbar.
EUVIMED